Yao Liu

5.3k total citations · 1 hit paper
283 papers, 3.4k citations indexed

About

Yao Liu is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Yao Liu has authored 283 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 50 papers in Pathology and Forensic Medicine and 44 papers in Molecular Biology. Recurrent topics in Yao Liu's work include Lymphoma Diagnosis and Treatment (36 papers), CAR-T cell therapy research (20 papers) and Viral-associated cancers and disorders (19 papers). Yao Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), CAR-T cell therapy research (20 papers) and Viral-associated cancers and disorders (19 papers). Yao Liu collaborates with scholars based in China, United States and Macao. Yao Liu's co-authors include Xi Zhang, Lei Gao, Li Gao, Jiang F. Zhong, Cheng Zhang, Peiwei Hong, Ruihao Huang, Wen Zhu, Wen Qin and Xiaoping Li and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yao Liu

258 papers receiving 3.4k citations

Hit Papers

Recent advances in CAR-T cell engineering 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao Liu China 28 907 691 526 361 337 283 3.4k
Jianfeng Li China 34 1.7k 1.9× 961 1.4× 243 0.5× 550 1.5× 259 0.8× 162 4.7k
Wenli Zhang China 31 1.1k 1.2× 268 0.4× 608 1.2× 336 0.9× 227 0.7× 232 3.7k
Ju Liu China 40 2.2k 2.5× 645 0.9× 517 1.0× 1.1k 3.1× 422 1.3× 342 6.2k
Zhiwei Huang China 30 908 1.0× 289 0.4× 549 1.0× 402 1.1× 85 0.3× 188 3.6k
Ping Zhu China 41 2.4k 2.6× 331 0.5× 727 1.4× 442 1.2× 342 1.0× 254 5.7k
Yifan Zhang China 37 1.9k 2.1× 499 0.7× 308 0.6× 832 2.3× 243 0.7× 209 4.7k
Zheng Li China 32 1.3k 1.5× 1.2k 1.8× 260 0.5× 497 1.4× 172 0.5× 232 3.7k
Lina Zhou China 39 2.4k 2.6× 552 0.8× 544 1.0× 680 1.9× 248 0.7× 222 5.6k
Weiwei Wang China 38 2.5k 2.7× 660 1.0× 455 0.9× 420 1.2× 342 1.0× 283 5.6k
Yonggoo Kim South Korea 30 1.1k 1.3× 429 0.6× 218 0.4× 466 1.3× 234 0.7× 333 4.0k

Countries citing papers authored by Yao Liu

Since Specialization
Citations

This map shows the geographic impact of Yao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Liu more than expected).

Fields of papers citing papers by Yao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Liu. The network helps show where Yao Liu may publish in the future.

Co-authorship network of co-authors of Yao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Liu. A scholar is included among the top collaborators of Yao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Liu. Yao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lu, Hua, Yao Liu, Jiabei Wang, et al.. (2025). Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis. The EMBO Journal. 44(5). 1414–1441. 3 indexed citations
3.
Liu, Yao, et al.. (2025). Dupilumab-Induced Systemic Hypoperfusion in an Elderly Patient: A Case Report. Journal of Inflammation Research. Volume 18. 18323–18329.
4.
Zhang, Yi, et al.. (2024). Oridonin attenuates diabetic retinopathy progression by suppressing NLRP3 inflammasome pathway. Molecular and Cellular Endocrinology. 596. 112419–112419. 2 indexed citations
5.
Lin, Xiaojuan, Mingyi Xu, Feng Ji, et al.. (2024). Environmental Surveillance of Human Astroviruses in Jinan City of China, 2020–2021. Food and Environmental Virology. 16(1). 50–57. 1 indexed citations
6.
Huang, Liang, Heng Mei, Yuhua Li, et al.. (2024). Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China. Journal for ImmunoTherapy of Cancer. 12(5). e008553–e008553. 10 indexed citations
9.
Liu, Yao, Qixuan Lin, Ruonan Zhu, et al.. (2023). Gamma-valerolactone-enabled control chemoselective conversion of glucose to 1,6-anhydroglucose over HZSM-5 zeolite. Applied Catalysis B: Environmental. 344. 123623–123623. 8 indexed citations
10.
Hong, Huangming, Le Yu, Zhihui Zhang, et al.. (2023). Primary breast diffuse large B‐cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group. Cancer Medicine. 12(23). 21188–21198. 2 indexed citations
11.
Chen, Yue, et al.. (2023). Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China. BMC Medical Informatics and Decision Making. 23(1). 125–125. 3 indexed citations
12.
Liang, Xiping, et al.. (2023). Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era. Experimental Hematology. 122. 1–9. 4 indexed citations
13.
Liu, Kexin, et al.. (2023). Reduced Allergenicity of Shrimp (Penaeus vannamei) by Altering the Protein Fold, Digestion Susceptibility, and Allergen Epitopes. Journal of Agricultural and Food Chemistry. 71(23). 9120–9134. 27 indexed citations
14.
Hong, Peiwei, et al.. (2022). Transcranial direct current stimulation for migraine: a systematic review and meta‐analysis of randomized controlled trials. CNS Neuroscience & Therapeutics. 28(7). 992–998. 20 indexed citations
15.
Wang, Li, Jianda Hu, Wenbin Qian, et al.. (2021). Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China. Cancer Communications. 41(3). 229–239. 17 indexed citations
16.
17.
Liu, Yao, et al.. (2021). Management of tuberculosis outbreaks in middle schools of Bijie City. Chinese Journal of School Health. 1 indexed citations
18.
Wang, Ping, et al.. (2020). Clinical efficacy of sirolimus in treatment of relapsed and refractory autoimmune hemolytic anemia in adults. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Liu, Yao, Zhe Yang, Li Zhang, et al.. (2018). Albumin/sulfonamide stabilized iron porphyrin metal organic framework nanocomposites: targeting tumor hypoxia by carbonic anhydrase IX inhibition and T₁–T₂ dual mode MRI guided photodynamic/photothermal therapy. Journal of Materials Chemistry. 1 indexed citations
20.
Liao, Yan, et al.. (2012). Feasibility of a small mount of water intake at early stage after general anesthesia in children. Zhonghua mazuixue zazhi. 32(3). 282–283. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026